Pomdoctor Limited American Stock Performance
| POM Stock | 0.24 0.01 4.35% |
The company holds a Beta of -1.75, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning POMDOCTOR LIMITED are expected to decrease by larger amounts. On the other hand, during market turmoil, POMDOCTOR LIMITED is expected to outperform it. At this point, POMDOCTOR LIMITED has a negative expected return of -1.86%. Please make sure to check POMDOCTOR LIMITED's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if POMDOCTOR LIMITED performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days POMDOCTOR LIMITED American has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Is POMs Stock the Next Big Bet - StocksToTrade | 12/10/2025 |
2 | Exelon Names Tim Peterson Chief Customer and Technology Officer | 01/08/2026 |
3 | POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies | 01/16/2026 |
4 | Polyoxymethylene Market Size Projected at 1.80 Million Tons by 2026 | 01/22/2026 |
5 | INVESTOR ALERT Class Action Lawsuit Filed on Behalf of POMDOCTOR LIMITED Investors Holzer Holzer, LLC Encourages Investors With Significant Losses to Contact th... | 02/06/2026 |
6 | ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM | 02/11/2026 |
| Begin Period Cash Flow | 6.8 M | |
| Total Cashflows From Investing Activities | -33.4 K |
POMDOCTOR | Build AI portfolio with POMDOCTOR Stock |
POMDOCTOR LIMITED Relative Risk vs. Return Landscape
If you would invest 381.00 in POMDOCTOR LIMITED American on November 14, 2025 and sell it today you would lose (357.00) from holding POMDOCTOR LIMITED American or give up 93.7% of portfolio value over 90 days. POMDOCTOR LIMITED American is generating negative expected returns assuming volatility of 13.9797% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than POMDOCTOR, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
POMDOCTOR LIMITED Target Price Odds to finish over Current Price
The tendency of POMDOCTOR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.24 | 90 days | 0.24 | about 77.27 |
Based on a normal probability distribution, the odds of POMDOCTOR LIMITED to move above the current price in 90 days from now is about 77.27 (This POMDOCTOR LIMITED American probability density function shows the probability of POMDOCTOR Stock to fall within a particular range of prices over 90 days) .
POMDOCTOR LIMITED Price Density |
| Price |
Predictive Modules for POMDOCTOR LIMITED
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as POMDOCTOR LIMITED. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.POMDOCTOR LIMITED Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. POMDOCTOR LIMITED is not an exception. The market had few large corrections towards the POMDOCTOR LIMITED's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold POMDOCTOR LIMITED American, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of POMDOCTOR LIMITED within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.18 | |
β | Beta against Dow Jones | -1.75 | |
σ | Overall volatility | 2.14 | |
Ir | Information ratio | -0.18 |
POMDOCTOR LIMITED Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of POMDOCTOR LIMITED for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for POMDOCTOR LIMITED can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| POMDOCTOR LIMITED generated a negative expected return over the last 90 days | |
| POMDOCTOR LIMITED has high historical volatility and very poor performance | |
| POMDOCTOR LIMITED has some characteristics of a very speculative penny stock | |
| POMDOCTOR LIMITED has a very high chance of going through financial distress in the upcoming years | |
| POMDOCTOR LIMITED American has 441.1 M in debt with debt to equity (D/E) ratio of 1.36, which is OK given its current industry classification. POMDOCTOR LIMITED has a current ratio of 0.51, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable POMDOCTOR to fund expansion initiatives and generate superior returns. | |
| The entity reported the last year's revenue of 342.56 M. Reported Net Loss for the year was (37.37 M) with profit before taxes, overhead, and interest of 0. | |
| POMDOCTOR LIMITED American has about 57 M in cash with (16.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Latest headline from globenewswire.com: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM |
POMDOCTOR LIMITED Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of POMDOCTOR Stock often depends not only on the future outlook of the current and potential POMDOCTOR LIMITED's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. POMDOCTOR LIMITED's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 118.4 M | |
| Cash And Short Term Investments | 7.7 M |
POMDOCTOR LIMITED Fundamentals Growth
POMDOCTOR Stock prices reflect investors' perceptions of the future prospects and financial health of POMDOCTOR LIMITED, and POMDOCTOR LIMITED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on POMDOCTOR Stock performance.
| Price To Earning | 22.44 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 342.56 M | ||||
| EBITDA | (24.27 M) | ||||
| Net Income | (37.37 M) | ||||
| Cash And Equivalents | 57 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 441.1 M | ||||
| Debt To Equity | 1.36 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | 21.28 X | ||||
| Cash Flow From Operations | (16.13 M) | ||||
| Market Capitalization | 6.6 B | ||||
| Total Asset | 46.23 M | ||||
| Retained Earnings | (2.26 B) | ||||
| Working Capital | (141.65 M) | ||||
| Current Asset | 1.2 B | ||||
| Current Liabilities | 2.31 B | ||||
About POMDOCTOR LIMITED Performance
By examining POMDOCTOR LIMITED's fundamental ratios, stakeholders can obtain critical insights into POMDOCTOR LIMITED's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that POMDOCTOR LIMITED is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 13.05 | 17.24 | |
| Return On Tangible Assets | (2.79) | (2.93) | |
| Return On Capital Employed | 0.22 | 0.36 | |
| Return On Assets | (2.79) | (2.93) | |
| Return On Equity | 0.07 | 0.08 |
Things to note about POMDOCTOR LIMITED performance evaluation
Checking the ongoing alerts about POMDOCTOR LIMITED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for POMDOCTOR LIMITED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| POMDOCTOR LIMITED generated a negative expected return over the last 90 days | |
| POMDOCTOR LIMITED has high historical volatility and very poor performance | |
| POMDOCTOR LIMITED has some characteristics of a very speculative penny stock | |
| POMDOCTOR LIMITED has a very high chance of going through financial distress in the upcoming years | |
| POMDOCTOR LIMITED American has 441.1 M in debt with debt to equity (D/E) ratio of 1.36, which is OK given its current industry classification. POMDOCTOR LIMITED has a current ratio of 0.51, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable POMDOCTOR to fund expansion initiatives and generate superior returns. | |
| The entity reported the last year's revenue of 342.56 M. Reported Net Loss for the year was (37.37 M) with profit before taxes, overhead, and interest of 0. | |
| POMDOCTOR LIMITED American has about 57 M in cash with (16.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Latest headline from globenewswire.com: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM |
- Analyzing POMDOCTOR LIMITED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether POMDOCTOR LIMITED's stock is overvalued or undervalued compared to its peers.
- Examining POMDOCTOR LIMITED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating POMDOCTOR LIMITED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of POMDOCTOR LIMITED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of POMDOCTOR LIMITED's stock. These opinions can provide insight into POMDOCTOR LIMITED's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in POMDOCTOR LIMITED American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.